Vascular Solutions Reports Third Quarter Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/24/2026
- S&P 500 ends marginally lower as investors focus on US-Iran war
- Oracle triggers force majeure on massive 'Project Jupiter' data center
- Oil gains on little sign of progress in US-Iran talks
- S&P 500 history shows strong gains across Fed hiking cycles: BCA
- JPMorgan upgrades CoreWeave on stronger compute pricing
- Plug Power COO resigns to join another company
- Bloom Energy falls as Oracle invokes force majeure on AI project
- Oracle triggers force majeure on massive 'Project Jupiter' data center
- Oracle Sends Force Majeure Notice Over New Mexico Data Center - Bloomberg
- Akamai signs $11.6B deal with Anthropic, up to $20B potential
Needham & Company Reiterates Buy on Vascular Solutions (VASC) Following 3Q Report
October 25, 2016 8:32 AM EDTNeedham & Company reiterated a Buy rating and $58.00 price target on Vascular Solutions (NASDAQ: VASC) following the company's 3Q earnings report. Revenue was reported in-line with consensus at $41.8M. Adjusted EPS was $0.31 vs. consensus of $0.30. The EPS upside was driven by a lower than expected... More
Vascular Solutions (VASC) Tops Q3 EPS by 1c; Issues Solid Outlook
October 24, 2016 4:09 PM EDTVascular Solutions (NASDAQ: VASC) reported Q3 EPS of $0.31, $0.01 better than the analyst estimate of $0.30. Revenue for the quarter came in at $41.8 million versus the consensus estimate of $41.65 million.
GUIDANCE:
Vascular Solutions sees Q4 2016 EPS of $0.34-$0.36, versus the consensus of... More
